You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials Completed
329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021292023
Dec 2021100012
Jan 202266015
Feb 20225608
Mar 2022180010
Apr 20227805
May 202256017
Jun 202238010
Jul 20224008
Aug 20227407
Sep 202294012
Oct 20227207
Nov 20228805
Dec 202211401
Jan 202313402
Feb 202317403
Mar 202319807
Apr 202312603
May 202318005
Jun 202315600
Jul 202322208
Aug 202317004
Sep 202321006
Oct 202314805
Nov 202314001
Dec 202317809
Jan 20246003
Feb 202412207
Mar 20242140116
Total37800319